Actelion Sucks Customer Reviews and Feedback
Actelion is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel, Switzerland.Actelion focuses on the manufacture of drugs that treat rare diseases and orphan diseases. Some of the drugs it has produced have been used to treat patients with symptoms related to central nervous system disorders, irregular heart conditions, immune system disorders and cancer. One of the focuses of Actelion is treating individuals with Pulmonary Arterial Hypertension (PAH), a heart condition that leaves patients with a short life expectancy (7-9 years) even with treatment.
Medical Xpress shared an article published by The Associated Press: "Drug company Actelion to pay $360M in kickback probe. The U.S. attorney's office in Boston announced the settlement Thursday with Actelion Pharmaceuticals US Inc., which was acquired last year by health care giant Johnson & Johnson. Federal prosecutors say South San Francisco-based Actelion illegally used a purportedly independent charity to cover the co-payments of thousands of Medicare patients taking its pulmonary arterial high blood pressure drugs. Prosecutors say that helped the company convince patients to buy its drugs when the prices it set would have otherwise prevented them from doing so."
Current Employee - Director says"Unintelligent group of people. Basically dysfunctional"
Former Employee - Kam says"They are shameless bullies and have been for years."
Current Employee - Senior Clinical Research Associate says"The leadership is very dysfunctional and you survive if you bully. Unless you are French you can't go very far. There is discriminatory behavior ."
Former Employee - Clinical Pharmacology says"- Bullying culture - Incompetent leadership - You do as you are told - Low moral"
Sales says"Bullying culture with lots of people complaining but managers at all levels simply ignoring it. Do not work for this company,."
says"bad treatment of staff, should be improved strong emotions . . . . . . . . ."
Current Employee - Territory Manager says"Toxic culture From top Leadership bonus structure"
Current Employee - Anonymous Employee says"With the merger, even though not much has changed, the pressure and culture is changing. My current manager is a micromanager and creates an environment based on criticism and bullying. I want to run but need a job."
says"lack of communication from management"
Current Employee - Anonymous Employee says"make very poor management decisions, and deceive the sales teams in a very manipulative manner. Very unprofessional for such an experienced and high performing sales staff."
Text & Artwork Coordinator (Former Employee) says"I was surprised at how management of the department I was in allowed two employees to set and maintain a negative tone constantly. There was no reprimanding them or even letting them go which would have been normal in another organisation. The pharmaceutical industry is not for me anyway but I would have stuck out my year's contract but for the nastiness I had to face daily in the office. The other departments had very decent folk some with whom I am still friends. I was employed through a recruitment service which meant that when I needed assistance from Actelion HR, they didn't want to know although when they realised I was athletic and sporty, they asked me to be part of their competitive Bike-to-Work scheme!"
Corporate Services Specialist (Former Employee) says"Typical day at work is calm and busy Learned Johnson & Johnson merger with Actelion Management is alright Diverse The hardest part was not able to understand lower workers, due to language barier The most enjoyable was serving the employees"
National Account Manager (Former Employee) says"Actelion-great rare orphan-disease experience. Excellent PAH and Market Access Experience. Acquisition by Janssen has allowed access to greater resources."
Senior District Manager (Current Employee) says"Currently a lot in flux with the acquisition from Johnson & Johnson we are not sure what is going on. very stressful times at co management is also kept in dark about the futuregood paystress times"
Leslie L. Lake says"PERTinent Updates — Issue 31 - Sponsored by Actelion®: https://t.co/UbiNHBzESx"
PERT Consortium says"PERTinent Updates — Issue 31 - Sponsored by Actelion® - https://t.co/LMZDvnaWLD"
Scleroderma Info says"Talks and Workshops for Scleroderma. https://t.co/43TwwAc0ct #scleroderma @actelion_com @boehringerus @Boehringer… https://t.co/572wfwzl8q"
In The News
Reuters reports"How Sanofi lost out to J&J in $30 billion battle for Actelion"
Bloomberg Law reports"J&J's Actelion, Nippon Sue to Block Copies of Uptravi Lung Drug"
StartupNG reports"Metabolic Disorder Therapeutics Market End-use Sectors Analysis 2019-2025"
Weekly Wall reports"Current and Future Trend of Anti Diarrheal Drugs Market, Analysis and Forecast for 2020-2026 | Actelion, Lupin, GSK, Glenmark Pharmaceuticals"